https://www.gsk.com/en-gb/media/press-releases/medicago-and-gsk-start-phase-3-trial-of-adjuvanted-covid-19-vaccine-candidate/
During the span of the COVID-19 pandemic, mRNA vaccines have gone from being promising technology in the lab to blockbuster products in the real world. In the pandemic's second year, Medicago is hopin
以上內容由「Cofacts 真的假的」訊息回報機器人與查證協作社群提供,以 CC授權 姓名標示-相同方式分享 4.0 (CC BY-SA 4.0) 釋出,於後續重製或散布時,原社群顯名及每一則查證的出處連結皆必須被完整引用。